Skip to main content
logo
Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,360.00
0.00 (0.00%)
At close: Aug 11, 2026

Kolmar BioTech Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3,677-5,547225.3-5,054-1,880-1,926
Depreciation & Amortization
3,6973,7724,2024,3234,2472,701
Loss (Gain) From Sale of Assets
-210.48-181.4748.6-27.261.7753.59
Asset Writedown & Restructuring Costs
693.21693.21-560.38---
Loss (Gain) From Sale of Investments
120.37130.0650.13-5.51875.87-1,182
Loss (Gain) on Equity Investments
2.312.313---
Provision & Write-off of Bad Debts
-101.77163.82-283.78-483.71-188.85-278.63
Other Operating Activities
-210.31-170.26-1,688436.36-1,261-401.15
Change in Accounts Receivable
-1,2241,647956.46-4,4423,499-732.74
Change in Inventory
-3,513-2,84438.75-424.431,177-474.57
Change in Accounts Payable
2,466458.961,952-269.69-148.15349.66
Change in Income Taxes
-----11.68-22.01
Change in Other Net Operating Assets
-1,7801,245-6,0702,725-3,8693,640
Operating Cash Flow
-3,737-630.5-1,126-3,2222,5021,728
Operating Cash Flow Growth
----44.82%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-79.45-253.96-292.45-842.88-11,422-36,684
Sale of Property, Plant & Equipment
247.62219.29101.5280.64344.5672.77
Sale (Purchase) of Intangibles
-4.72-5.33-17.06-51.36-87.9754.36
Investment in Securities
-34,318679.13-882.87880.314,8306,891
Other Investing Activities
1,2081,54143.1869.16-345.79228.64
Investing Cash Flow
-32,9442,182-1,048135.86-6,681-29,437

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-2,2712,43912,7008,5813,700
Long-Term Debt Issued
-1,00030,00014,313-24,000
Total Debt Issued
38,2713,27132,43927,0138,58127,700
Short-Term Debt Repaid
--3,000-10,357-5,830-10,099-2,785
Long-Term Debt Repaid
--1,905-23,534-16,285-545.31-1,032
Total Debt Repaid
-5,141-4,906-33,892-22,115-10,645-3,817
Net Debt Issued (Repaid)
33,131-1,634-1,4534,898-2,06423,883
Issuance of Common Stock
--2,043---
Other Financing Activities
-90.21-103.02186.0527.36148.55172.78
Financing Cash Flow
33,040-1,737775.924,9257,30224,056

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.3-1.110.66-1.36-0.44
Miscellaneous Cash Flow Adjustments
-0-----
Net Cash Flow
-3,641-185.69-1,3971,8403,122-3,653

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3,817-884.46-1,419-4,065-8,919-34,956
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.47%-2.35%-3.28%-10.53%-19.01%-111.90%
Free Cash Flow Per Share
-228.85-47.66-94.47-317.71-692.61-2922.44
Levered Free Cash Flow
30,2121,217-7,219-8,994-5,372-24,716
Unlevered Free Cash Flow
31,9853,025-5,202-6,979-3,624-24,311

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2,1452,1722,5622,3471,217813.03
Cash Income Tax Paid
8.187.67-3.69-5.93-7.35-7.21
Change in Working Capital
-4,051506.73-3,123-2,411647.412,760